Claude Martin

Title: Claude Martin - Innovator in Radioactive Markers

Introduction

Claude Martin is an accomplished inventor based in Grasse, France, known for his significant contributions to the field of biochemistry through his innovative work in radioactive markers. With one patent to his name, Martin has made strides in enhancing the understanding and application of nuclear receptors and retinoids.

Latest Patents

His notable patent, titled "Compound marked with tritium, its preparation and its use in particular - 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl) benzoic acid marked with tritium," highlights the utility of this compound as a radioactive marker. This invention plays a crucial role in the titration of nuclear receptors and cellular retinoic acid-binding protein (CRABP). The compound assists in measuring the affinity of retinoids for these receptors, conducting titrations of known retinoids, characterizing antibodies directed against this benzoic acid, and studying the distribution and metabolism of said benzoic acid derivative.

Career Highlights

Claude Martin currently works at the Centre International de Recherches Dermatologiques, where his research contributes to advancements in dermatological sciences. His expertise in radioactive markers is pivotal in promoting further understanding of biochemical processes related to skin health and diseases.

Collaborations

Throughout his career, Martin has collaborated with several esteemed colleagues, including Braham Shroot and Yves M. Darmon. These collaborations enhance the breadth and depth of research, facilitating innovative findings and applications in dermatological research.

Conclusion

Claude Martin stands out as a key inventor in the field of biochemistry, particularly in the utilization of radioactive markers for scientific advancements. His patent significantly aids in the study of nuclear receptors and retinoids, showcasing the impact of innovative thinking in tackling complex biochemical challenges.